Clinical Trials Browser

Phase 3 × Interventional × Liposomes × Clear all

NCT04293562 2026-05-05

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00002105 2005-06-24

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002147 2005-06-24

Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002318 2005-06-24

A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma

Phase 3 Unknown

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002319 2005-06-24

A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma

Phase 3 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections